CRISPR Therapeutics AGCRSPNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.40
Net Income/Share$-5.35
Operating CF/Share$-3.31
Free CF/Share$-3.32
Cash/Share$20.98
Book Value/Share$20.98
Tangible Book/Share$20.98
Equity/Share$20.98
Interest Debt/Share$2.31
CapEx/Share$0.01
Dividend/Share$0.00
Valuation
Market Cap$4.76B
Enterprise Value$4.69B
P/E Ratio-9.34P/S Ratio129.54P/OCF Ratio-15.08
P/FCF Ratio-15.71
P/B Ratio2.38P/TB Ratio2.38
EV/Sales127.49EV/EBITDA-8.85
Graham Valuation
Graham Number--
Graham Net-Net$17.37
Profitability
Earnings Yield-10.70%FCF Yield-6.37%ROE-26.44%ROIC-26.78%Return on Tangible Assets-21.75%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-0.22%
CapEx/Revenue1.77%
CapEx/Depreciation0.03
SBC/Revenue207.79%
SG&A/Revenue199.34%
R&D/Revenue1033.05%
Liquidity & Solvency
Debt/Equity0.11Debt/Assets0.09Debt/Market Cap0.04
Net Debt/EBITDA0.14
Current Ratio16.22Interest Coverage0.00xIncome Quality0.62Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding26 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover14.19x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$1.92B
Working Capital$1.81B
Invested Capital$2.07B
Intangibles/Assets0.00%